Chronic cough, defined as a cough persisting for more than eight weeks, poses a significant diagnostic and therapeutic challenge to clinicians. This article aims to elucidate a comprehensive approach to diagnosing and managing this common yet perplexing condition.
Chronic cough can be attributed to a multitude of factors such as upper airway cough syndrome, gastroesophageal reflux disease, and non-asthmatic eosinophilic bronchitis. Understanding the pathophysiology of these conditions is crucial to formulating an effective treatment plan.
Diagnosis of chronic cough should be systematic and comprehensive, beginning with a thorough history and physical examination. The use of objective tools like chest radiographs, spirometry, and bronchoprovocation tests can provide valuable insights. If initial investigations are inconclusive, consider more specialized tests such as high-resolution computed tomography or bronchoscopy.
Treatment should be etiology-specific and patient-centered. Empirical therapy for the most common causes may be initiated, but if the cough persists, targeted therapy based on diagnostic tests should be considered. Non-pharmacological measures, including behavioral therapy and physiotherapy, can also play a crucial role in management.
Despite advances in understanding and managing chronic cough, challenges persist. These include the lack of standardized diagnostic criteria and the paucity of effective treatments for refractory cases. Future research should focus on developing novel diagnostic tools and therapeutic agents, as well as exploring the role of personalized medicine in managing chronic cough.
Chronic cough is a complex condition that requires a comprehensive and systematic approach to diagnosis and treatment. By understanding its etiology and pathophysiology, employing a thorough diagnostic process, and utilizing targeted treatment strategies, clinicians can effectively manage this condition and significantly improve patients' quality of life.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation